Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed M Dar

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Oncologist|December 15, 2010
Phase I study of pazopanib in combination with weekly paclitaxel in patients with advanced solid tumorsAntoinette R Tan, Afshin Dowlati, Suzanne F Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2013
A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant gliomaDavid A Reardon, Morris D Groves, Patrick Y Wen, et al.
Molecular Cancer Therapeutics|June 9, 2012
Phase I study of pazopanib in combination with paclitaxel and carboplatin given every 21 days in patients with advanced solid tumorsHoward A Burris, Afshin Dowlati, Rebecca A Moss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancerMichael J Robertson, James W Mier, Theodore Logan, et al.
British Journal of Clinical Pharmacology|February 14, 2015
Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal functionLot A Devriese, Petronella Els O Witteveen, Marja Mergui-Roelvink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2011
Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignanciesDavid Olmos, Douglas Barker, Rohini Sharma, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Oncologist|December 15, 2010
Phase I study of pazopanib in combination with weekly paclitaxel in patients with advanced solid tumorsAntoinette R Tan, Afshin Dowlati, Suzanne F Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2013
A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant gliomaDavid A Reardon, Morris D Groves, Patrick Y Wen, et al.
Molecular Cancer Therapeutics|June 9, 2012
Phase I study of pazopanib in combination with paclitaxel and carboplatin given every 21 days in patients with advanced solid tumorsHoward A Burris, Afshin Dowlati, Rebecca A Moss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancerMichael J Robertson, James W Mier, Theodore Logan, et al.
British Journal of Clinical Pharmacology|February 14, 2015
Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal functionLot A Devriese, Petronella Els O Witteveen, Marja Mergui-Roelvink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2011
Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignanciesDavid Olmos, Douglas Barker, Rohini Sharma, et al.
Pageof 2